|
CANCER INFORMATION SERVICE
|
N02CO511001-013
|
$207,748
|
|
ABIDI, SYED
|
SLOAN KETTERING INSTITUTION FOR CANCER R
|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185 10318
|
$170,288
|
|
Abnet, Christian
|
DCEG (NCI)
|
|
Cancer screening among Latinas
|
5R21CA134247-02
|
$212,520
|
|
ABRAIDO-LANZA, ANA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Using Email to Enhance Counseling Services at NCI's Smoking Cessation Quitline
|
5K07CA124579-03
|
$134,528
|
|
ABROMS, LORIEN
|
GEORGE WASHINGTON UNIVERSITY
|
|
MRI for In Vivo Quantification of Yttrium-90 Microsphere Biodistribution
|
1F31CA150658-01
|
$31,692
|
|
Adeyanju, Oyinlolu
|
NORTHWESTERN UNIVERSITY
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
1R01CA140368-01A1
|
$313,408
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed Extract
|
5R01CA091883-08
|
$332,558
|
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Prevention and Treatment by Silibinin
|
5R01CA102514-07
|
$332,920
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Chemoprevention by Inositol Hexaphosphate Efficacy and Mechanism
|
5R01CA116636-05
|
$261,068
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Barriers to CRC in patients with mental illness.
|
5R03CA137825-02
|
$69,345
|
|
AGGARWAL, ARPITA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
SELECT Pre-Clinical Trial of Prostate Cancer
|
5R01CA114060-05
|
$250,774
|
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-05
|
$754,460
|
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Epigenetic markers involved in colorectal cancer recurrence and metastases
|
5K23CA127141-03
|
$140,940
|
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Mechanisms of T cell leukemia induction and maintenance
|
1R01CA149655-01
|
$350,675
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha
|
1R01CA138671-01A1
|
$319,550
|
|
Ajani, Jaffer
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Molecular Biomarkers as Classifiers to Individualize Therapy of Esophagus Cancer
|
5R21CA129906-02
|
$183,294
|
|
Ajani, Jaffer
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
|
5SC2CA138179-03
|
|
|
AKALA, EMMANUEL
|
HOWARD UNIVERSITY
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-05
|
$138,381
|
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
|
5P20CA138018-03
|
$132,788
|
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
|
5R01CA120552-05
|
$248,463
|
|
AKPORIAYE, EMMANUEL
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Modeling causes and consequences of the evolution of cell motility in neoplasms
|
1F32CA144331-01
|
$50,474
|
|
Aktipis, Christina
|
UNIVERSITY OF ARIZONA
|
|
Studies of Occupational Cancer (Pesticides)
|
Z01 CP010119
|
$1,978,544
|
$191,619
|
Alavanja
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$143,853
|
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Cancer Prevention and Control Translational Research
|
2R25CA078447-11
|
$500,000
|
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$7,266
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$2,265
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$6,558
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$1,763
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$82,488
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Amplicons in Oral Dysplasia
|
5R01CA131286-03
|
$270,000
|
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cellular MRI in Glioma and Radiation Necrosis
|
5R01CA122031-04
|
$247,950
|
|
ALI, SYED
|
HENRY FORD HEALTH SYSTEM
|
|
Protein Kinase C and GSTP1 interactions in glioma drug resistance
|
5R01CA127872-03
|
$323,700
|
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-02
|
$584,016
|
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Assessing Localized Prostate Cancer Post-Treatment Outcomes Among Gay Men
|
5R03CA136114-02
|
$81,250
|
|
Allensworth-Davies, Donald
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A web-based tailored health behavior intervention for African American colon canc
|
5R03CA138118-02
|
$74,000
|
|
Allicock, Marlyn
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
SURFACE ANTIGENS OF MURINE T LYMPHOMAS
|
5R01CA040041-22
|
$311,649
|
$31,165
|
ALLISON, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-11
|
$288,775
|
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-02
|
$341,338
|
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
|
7R21CA129302-02
|
$208,628
|
|
Altomare, Deborah
|
UNIVERSITY OF CENTRAL FLORIDA
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$133,226
|
|
Ambs, Stefan
|
CCR (NCI)
|
|
Image-Guided Stereotactic Radiosurgery of Breast Cancer
|
5R44CA132254-04
|
$1,000,000
|
|
Amies, Christopher
|
XCISION MEDICAL SYSTEMS, LLC
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
1U19CA148127-01
|
$2,818,904
|
|
AMOS, CHRISTOPHER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Dietary Prevention of Cancer
|
5R01CA109269-07
|
$283,480
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Biobehavioral responses to cancer
|
2K05CA098133-06
|
$160,410
|
|
Andersen, Barbara
|
OHIO STATE UNIVERSITY
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
2P01CA078378-11A2
|
$2,056,275
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-18
|
$287,403
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$28,287
|
Anderson
|
DCEG (NCI)
|
|
Mechanistic Targeting of Lung Cancer
|
ZIA BC 005399
|
$540,198
|
|
Anderson, Lucy
|
CCR (NCI)
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$644,596
|
|
Anderson, Stephen
|
CCR (NCI)
|
|
General Descriptive Studies
|
ZIA CP010183 00350
|
$112,868
|
|
Anderson, William
|
DCEG (NCI)
|
Total relevant funding to Diabetes for this search: $9,248,610
|